FRMD4B

gene
On this page

Also known as KIAA1013GRSP1

Summary

FRMD4B (FERM domain containing 4B, HGNC:24886) is a protein-coding gene on chromosome 3p14.1, encoding FERM domain-containing protein 4B (Q9Y2L6). Member of GRP1 signaling complexes that are acutely recruited to plasma membrane ruffles in response to insulin receptor signaling.

This gene encodes a GRP1-binding protein which contains a FERM protein interaction domain as well as two coiled coil domains. This protein may play a role as a scaffolding protein.

Source: NCBI Gene 23150 — RefSeq curated summary.

At a glance

  • GWAS associations: 17
  • Clinical variants (ClinVar): 184 total
  • MANE Select transcript: NM_015123

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:24886
Approved symbolFRMD4B
NameFERM domain containing 4B
Location3p14.1
Locus typegene with protein product
StatusApproved
AliasesKIAA1013, GRSP1
Ensembl geneENSG00000114541
Ensembl biotypeprotein_coding
OMIM617467
Entrez23150

Gene structure

Transcript identifiers

Ensembl transcripts: 19 — 10 protein_coding, 5 retained_intron, 4 protein_coding_CDS_not_defined

ENST00000398540, ENST00000459638, ENST00000460709, ENST00000462308, ENST00000462512, ENST00000462888, ENST00000470070, ENST00000473029, ENST00000473188, ENST00000478263, ENST00000483668, ENST00000487751, ENST00000489817, ENST00000493127, ENST00000493880, ENST00000497475, ENST00000497757, ENST00000497880, ENST00000863518

RefSeq mRNA: 1 — MANE Select: NM_015123 NM_015123

CCDS: CCDS46863

Canonical transcript exons

ENST00000398540 — 23 exons

ExonStartEnd
ENSE000011492036916878269171981
ENSE000011754376917652469176656
ENSE000011754436918089969181710
ENSE000011754546918259869182717
ENSE000011754656918777069187917
ENSE000011754746918989669189952
ENSE000011754826919364869193873
ENSE000016972136919502269195141
ENSE000016993646919625569196396
ENSE000017251236919523169195364
ENSE000018403856938582869386088
ENSE000034754936919869869198774
ENSE000035008096930234369302435
ENSE000035475996931126369311357
ENSE000035767436921832269218379
ENSE000035829026924922669249248
ENSE000036209206919690069197038
ENSE000036209426925004369250099
ENSE000036280026922185869221923
ENSE000036367206928775269287836
ENSE000037588706931345269313517
ENSE000037878936921626369216349
ENSE000037894626922460769224690

Expression profiles

Bgee: expression breadth ubiquitous, 279 present calls, max score 97.08.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 14.6930 / max 475.2904, expressed in 1208 samples.

FANTOM5 promoters (28 alternative TSS)

Promoter IDTPM avgSamples expressed
429973.7712563
429641.9312362
429711.7103426
429781.3299218
429751.2851377
429950.8621292
429730.6595257
429980.5418231
429760.4592224
429820.3188126

Top tissues by expression

291 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
germinal epithelium of ovaryUBERON:000130497.08gold quality
calcaneal tendonUBERON:000370196.45gold quality
cortical plateUBERON:000534396.38gold quality
sural nerveUBERON:001548896.20gold quality
esophagus squamous epitheliumUBERON:000692095.96gold quality
corpus callosumUBERON:000233695.90gold quality
oral cavityUBERON:000016794.97gold quality
ganglionic eminenceUBERON:000402394.66gold quality
squamous epitheliumUBERON:000691494.40gold quality
tongue squamous epitheliumUBERON:000691993.87gold quality
parietal pleuraUBERON:000240093.58gold quality
palpebral conjunctivaUBERON:000181293.42gold quality
inferior vagus X ganglionUBERON:000536393.24gold quality
epithelium of esophagusUBERON:000197693.21gold quality
pleuraUBERON:000097792.63gold quality
gingival epitheliumUBERON:000194992.45gold quality
right lobe of thyroid glandUBERON:000111991.99gold quality
gingivaUBERON:000182891.94gold quality
subthalamic nucleusUBERON:000190691.87gold quality
thyroid glandUBERON:000204691.83gold quality
left lobe of thyroid glandUBERON:000112091.62gold quality
pharyngeal mucosaUBERON:000035591.41gold quality
synovial jointUBERON:000221791.27gold quality
parotid glandUBERON:000183191.21gold quality
cervix squamous epitheliumUBERON:000692291.05gold quality
visceral pleuraUBERON:000240190.91gold quality
esophagus mucosaUBERON:000246990.47gold quality
cranial nerve IIUBERON:000094190.31gold quality
monocyteCL:000057690.16gold quality
right lungUBERON:000216790.12gold quality

Single-cell (SCXA)

Detected in 9 experiment(s), a significant marker in 8.

ExperimentMarker?Max mean expression
E-GEOD-75367yes1796.26
E-MTAB-11268yes1665.06
E-HCAD-5yes302.77
E-HCAD-35yes100.05
E-HCAD-25yes62.56
E-ANND-3yes18.43
E-MTAB-6678yes10.53
E-GEOD-137537yes4.00
E-ANND-2no1002.32

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

219 targeting FRMD4B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-3924100.0072.092394
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-196A-5P100.0068.16684
HSA-MIR-196B-5P100.0068.16681
HSA-MIR-429100.0073.442698
HSA-MIR-200B-3P100.0073.312693
HSA-MIR-200C-3P100.0073.352685
HSA-MIR-4668-3P100.0068.742635
HSA-MIR-656-3P100.0072.152788
HSA-MIR-3163100.0077.238605
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-5692A100.0074.406850
HSA-MIR-450099.9972.722367
HSA-MIR-548AW99.9972.573559
HSA-MIR-186-5P99.9970.833707
HSA-MIR-453199.9969.703181
HSA-MIR-428299.9975.366408
HSA-MIR-548C-3P99.9974.017587
HSA-LET-7A-5P99.9872.291790
HSA-LET-7B-5P99.9872.311790
HSA-LET-7C-5P99.9872.291790
HSA-LET-7E-5P99.9872.291790
HSA-LET-7F-5P99.9872.561784
HSA-LET-7G-5P99.9872.371784
HSA-LET-7I-5P99.9872.371788
HSA-MIR-98-5P99.9872.331787

Literature-anchored findings (GeneRIF, showing 2)

  • SNP is located in a 3’ intronic region of the FRMD4B gene. FRMD4B as novel susceptibility loci for advanced heart failure. (PMID:20124441)
  • association between the intronic rs6787362 FRMD4B SNP and ischemic cardiomyopathy in a European-derived population, but not FRMD4B variants as susceptibility factors in common heart failure (PMID:20718813)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriofrmd4baENSDARG00000074599
danio_reriofrmd4bbENSDARG00000076496
mus_musculusFrmd4bENSMUSG00000030064
rattus_norvegicusFrmd4bENSRNOG00000007764
caenorhabditis_elegansWBGENE00008555

Paralogs (6): EZR (ENSG00000092820), ERMN (ENSG00000136541), RDX (ENSG00000137710), MSN (ENSG00000147065), FRMD4A (ENSG00000151474), NF2 (ENSG00000186575)

Protein

Protein identifiers

FERM domain-containing protein 4BQ9Y2L6 (reviewed: Q9Y2L6)

Alternative names: GRP1-binding protein GRSP1

All UniProt accessions (9): C9J6Q2, C9J7M5, C9JA15, C9JAW0, C9JBX2, C9JYK2, E9PGA7, Q9Y2L6, H7C550

UniProt curated annotations — full annotation on UniProt →

Function. Member of GRP1 signaling complexes that are acutely recruited to plasma membrane ruffles in response to insulin receptor signaling. May function as a scaffolding protein that regulates epithelial cell polarity by connecting ARF6 activation with the PAR3 complex. Plays a redundant role with FRMD4A in epithelial polarization.

Subunit / interactions. Interacts with CYTH3. Interacts with PARD3. Interacts with CYTH1.

Subcellular location. Cytoplasm. Cytoskeleton. Cell junction. Tight junction. Adherens junction.

Isoforms (2)

UniProt IDNamesCanonical?
Q9Y2L6-11yes
Q9Y2L6-22

RefSeq proteins (1): NP_055938* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000299FERM_domainDomain
IPR011993PH-like_dom_sfHomologous_superfamily
IPR014352FERM/acyl-CoA-bd_prot_sfHomologous_superfamily
IPR018979FERM_NDomain
IPR018980FERM_PH-like_CDomain
IPR019747FERM_CSConserved_site
IPR019748FERM_centralDomain
IPR019749Band_41_domainDomain
IPR021774CUPIDDomain
IPR029071Ubiquitin-like_domsfHomologous_superfamily
IPR035963FERM_2Homologous_superfamily
IPR041785FRMD4A/B_FERM_CDomain
IPR047176FRMD4A/BFamily

Pfam: PF00373, PF09379, PF09380, PF11819

UniProt features (28 total): compositionally biased region 8, region of interest 7, modified residue 4, coiled-coil region 2, cross-link 2, sequence conflict 2, chain 1, domain 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9Y2L6-F162.910.29

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (6): 372, 608, 697, 915, 882, 1029

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 325 (showing top): YAGI_AML_WITH_INV_16_TRANSLOCATION, GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY, GOBP_ESTABLISHMENT_OF_EPITHELIAL_CELL_POLARITY, KAAB_HEART_ATRIUM_VS_VENTRICLE_UP, ASTON_MAJOR_DEPRESSIVE_DISORDER_DN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, GOCC_RUFFLE, BILD_SRC_ONCOGENIC_SIGNATURE, GOBP_ESTABLISHMENT_OF_CELL_POLARITY, MARTINEZ_RB1_TARGETS_UP, ONKEN_UVEAL_MELANOMA_UP, MARTIN_VIRAL_GPCR_SIGNALING_DN, TIEN_INTESTINE_PROBIOTICS_24HR_UP, BROWNE_HCMV_INFECTION_6HR_UP

GO Biological Process (1): establishment of epithelial cell polarity (GO:0090162)

GO Molecular Function (0):

GO Cellular Component (7): ruffle (GO:0001726), obsolete extracellular space (GO:0005615), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), adherens junction (GO:0005912), bicellular tight junction (GO:0005923), anchoring junction (GO:0070161)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
establishment of cell polarity1
cell leading edge1
plasma membrane bounded cell projection1
intracellular anatomical structure1
cellular anatomical structure1
intracellular membraneless organelle1
cell-cell junction1
apical junction complex1
tight junction1
cell junction1

Protein interactions and networks

STRING

870 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
FRMD4BCYTH3O43739862
FRMD4BCYTH1Q15438855
FRMD4BCYTH4Q9UIA0629
FRMD4BCYTH2Q99418616
FRMD4BHSPB7Q9UBY9544
FRMD4BTMTC4Q5T4D3519
FRMD4BGPA33Q99795461
FRMD4BDYNLRB2Q8TF09433
FRMD4BPLEKHA5Q9HAU0425
FRMD4BNUSAP1Q9BXS6418
FRMD4BCPNE4Q96A23406
FRMD4BTMEM260Q9NX78398
FRMD4BMEIG1Q5JSS6383
FRMD4BCDKN2AP42771375
FRMD4BARL4AP40617374

IntAct

6 interactions, top by confidence:

ABTypeScore
FRMD4BAFDNpsi-mi:“MI:0915”(physical association)0.400
Xpo1IFT56psi-mi:“MI:0914”(association)0.350
FRMD4BZap70psi-mi:“MI:0914”(association)0.350
CYTH1CYTH3psi-mi:“MI:0914”(association)0.350
NFIBpsi-mi:“MI:0914”(association)0.350
RSPH1FRMD4Bpsi-mi:“MI:0915”(physical association)0.000

BioGRID (11): FRMD4B (Affinity Capture-MS), RNF146 (Affinity Capture-Western), FRMD4B (Affinity Capture-Luminescence), FRMD4B (Proximity Label-MS), MLLT4 (Affinity Capture-MS), FRMD4B (Affinity Capture-MS), FRMD4B (Proximity Label-MS), FRMD4B (Two-hybrid), FRMD4B (Affinity Capture-MS), FRMD4B (Affinity Capture-MS), FRMD4B (Affinity Capture-RNA)

ESM2 similar proteins: A0A0G2K2P5, A0JNJ1, B1WAP7, G9CGD6, O14640, O75122, O88382, O95049, O97758, P34908, P39447, P51141, P54792, P70175, Q05AS8, Q07157, Q16825, Q5F488, Q5IS48, Q5SGD7, Q5TCQ9, Q5XI81, Q61062, Q62136, Q62728, Q62936, Q6DKE2, Q6P9H4, Q6ZM86, Q812E4, Q86UL8, Q8BMA3, Q8IVH8, Q8JHI3, Q8TDW5, Q920B0, Q924I2, Q925T6, Q92997, Q95168

Diamond homologs: A2AEV7, Q3KP66, Q7TN12, Q920B0, Q96HB5, Q9Y2L6, A2ALK8, B0WYY2, F1LYQ8, F1P065, F8VPU2, O35763, O43491, O70318, O94887, P11171, P12264, P15311, P26038, P26040, P26041, P26042, P26043, P26044, P26045, P29074, P31976, P31977, P35240, P35241, P46150, P46662, P48193, P52962, P59750, P86232, Q12923, Q170J7, Q24564, Q29GR8

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

184 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance156
Likely benign7
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

3970 predictions. Top by Δscore:

VariantEffectΔscore
3:69176653:GACAC:Gacceptor_loss1.0000
3:69176654:ACACT:Aacceptor_loss1.0000
3:69176655:CA:Cacceptor_gain1.0000
3:69176656:ACTG:Aacceptor_loss1.0000
3:69176657:C:Aacceptor_loss1.0000
3:69176657:C:CCacceptor_gain1.0000
3:69176658:T:Aacceptor_loss1.0000
3:69182594:TTA:Tdonor_loss1.0000
3:69182595:TACT:Tdonor_loss1.0000
3:69182596:A:ACdonor_gain1.0000
3:69182596:A:Tdonor_loss1.0000
3:69182596:ACT:Adonor_gain1.0000
3:69182597:C:CCdonor_gain1.0000
3:69182597:CT:Cdonor_gain1.0000
3:69182597:CTC:Cdonor_gain1.0000
3:69182599:C:CAdonor_gain1.0000
3:69182713:TTTCT:Tacceptor_gain1.0000
3:69182714:TTCT:Tacceptor_gain1.0000
3:69182718:C:CCacceptor_gain1.0000
3:69189894:A:ACdonor_gain1.0000
3:69189895:C:CCdonor_gain1.0000
3:69189895:CGAT:Cdonor_gain1.0000
3:69189953:C:CCacceptor_gain1.0000
3:69193646:A:Tdonor_loss1.0000
3:69193647:C:Tdonor_loss1.0000
3:69194977:T:TAdonor_gain1.0000
3:69195020:A:ACdonor_gain1.0000
3:69195021:C:CCdonor_gain1.0000
3:69195021:CTT:Cdonor_gain1.0000
3:69195021:CTTCT:Cdonor_gain1.0000

AlphaMissense

6771 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
3:69196943:G:TA350E1.000
3:69196944:C:GA350P1.000
3:69196953:A:GW347R1.000
3:69196953:A:TW347R1.000
3:69196986:A:GW336R1.000
3:69196986:A:TW336R1.000
3:69198719:A:TV311D1.000
3:69198723:C:GA310P1.000
3:69198724:A:CF309L1.000
3:69198724:A:TF309L1.000
3:69198725:A:CF309C1.000
3:69198725:A:GF309S1.000
3:69198726:A:GF309L1.000
3:69198746:A:GL302S1.000
3:69198755:A:GL299P1.000
3:69198763:C:AW296C1.000
3:69198763:C:GW296C1.000
3:69198764:C:GW296S1.000
3:69198765:A:GW296R1.000
3:69198765:A:TW296R1.000
3:69216307:C:GG278R1.000
3:69216307:C:TG278R1.000
3:69216321:C:TG273E1.000
3:69216322:C:GG273R1.000
3:69216322:C:TG273R1.000
3:69216324:A:GL272P1.000
3:69181054:A:GL899S0.999
3:69195233:C:GA456P0.999
3:69196924:A:CF356L0.999
3:69196924:A:TF356L0.999

dbSNP variants (sampled 300 via entrez): RS1000007820 (3:69304711 T>G), RS1000008707 (3:69367413 C>T), RS1000020893 (3:69430986 C>A), RS1000026926 (3:69365567 C>T), RS1000040032 (3:69400167 C>G,T), RS1000040682 (3:69341725 G>A), RS1000045058 (3:69451176 T>A), RS1000049201 (3:69409297 T>A), RS1000049796 (3:69278590 G>C), RS1000055721 (3:69359031 C>T), RS1000084593 (3:69241957 G>A), RS1000089834 (3:69330897 G>A,T), RS1000094478 (3:69495929 A>C), RS1000115777 (3:69252398 C>T), RS1000117910 (3:69196021 C>G)

Disease associations

OMIM: gene MIM:617467 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

17 associations (top):

StudyTraitp-value
GCST000612_40Celiac disease2.000000e-07
GCST003818_26Resting heart rate3.000000e-15
GCST003902_1Fast beta electroencephalogram2.000000e-07
GCST003944_38Hepcidin/ferritin ratio3.000000e-06
GCST003944_39Hepcidin/ferritin ratio8.000000e-06
GCST006138_40Resting-state electroencephalogram vigilance8.000000e-06
GCST006414_78Atrial fibrillation3.000000e-09
GCST007045_21PR interval6.000000e-09
GCST008154_5Trunk fat mass3.000000e-07
GCST008865_6Sphingomyelin 24:0 levels1.000000e-06
GCST010064_2Celiac disease9.000000e-09
GCST010151_10Carotid intima media thickness x smoking interaction7.000000e-06
GCST010276_8Renal underexcretion gout1.000000e-07
GCST010321_112PR interval1.000000e-19
GCST010994_5High myopia2.000000e-08
GCST011996_2dexamethasone sensitivity in B-cell precursor acute lymphoblastic leukaemia3.000000e-06
GCST011997_2prednisolone sensitivity in B-cell precursor acute lymphoblastic leukaemia4.000000e-08

EFO canonical traits (6, from GWAS)

EFO IDTrait name
EFO:0004357electroencephalogram measurement
EFO:0007835alcohol dependence measurement
EFO:0007901hepcidin:ferritin ratio
EFO:0004462PR interval
EFO:0010118sphingomyelin measurement
EFO:0006527smoking status measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

37 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, decreases expression3
methylmercuric chloridedecreases expression2
Air Pollutantsdecreases expression, increases abundance2
Smokedecreases expression, increases abundance2
aristolochic acid Idecreases expression1
FR900359affects phosphorylation1
sotorasibaffects cotreatment, decreases expression1
triphenyl phosphateaffects expression1
propionaldehydedecreases expression1
trichostatin Aincreases expression1
sodium arsenitedecreases expression1
butyraldehydedecreases expression1
aflatoxin B2decreases methylation1
S-(1,2-dichlorovinyl)cysteineaffects cotreatment, decreases expression1
perfluorooctane sulfonic acidincreases expression1
abrineincreases expression1
trametinibdecreases expression, affects cotreatment1
(+)-JQ1 compounddecreases expression1
PCI 5002affects cotreatment, increases expression1
NVP-BKM120affects cotreatment, decreases expression1
Sunitinibdecreases expression1
Amphotericin Bdecreases expression1
Doxorubicindecreases expression1
Estradiolaffects cotreatment, increases expression1
Leadaffects methylation1
Lipopolysaccharidesaffects cotreatment, decreases expression1
Melphalandecreases expression1
Quercetindecreases expression1
Tetrachlorodibenzodioxinaffects cotreatment, increases expression1
Tretinoinincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): gout